Exabis Library
Welcome to the e-CCO Library!
P064: TOP1210 narrow spectrum kinase inhibitor demonstrates superior activity and improved safety profile potential compared with corticosteroid and immunomodulators in preclinical models of colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P065 Metabolic utilisation of propanediol by adherent-invasive E. coli regulates intestinal tissue immunity
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P0650: Comparative study between Kono-S and latero-lateral isoperistaltic anastomosis in the treatment of terminal ileum Crohn's Disease patients: perioperative complications and short-term results.
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0651: Evaluating tryptophan as a biomarker for treatment success in Inflammatory Bowel Disease patients undergoing therapy
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0652: Norovirus Infection May Be Responsible For More Severe Flares of Ulcerative Colitis
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0653: Patients with ileo-anal J-Pouch display alteredx7x7x7 higher pouch contractility than controls as measured with motility MRI.
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0654: Switching from intravenous to subcutaneous infliximab: physicians' practice and patients' satisfaction - Results from a nationwide transectional study.
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0655: VTE thromboprophylaxis in patients with inflammatory bowel disease admitted to hospital; can we increase adherence with guidelines?
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0656: Adalimumab mono vs. combination therapy in Crohn's Disease: Real world experience
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0657: Quality of ileocolic resection in Crohn’s disease- A systemic review and meta-analysis
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0658: Comparison of the Efficacy and Safety of Immunomodulator Use in Geriatric and Non-Geriatric Patients with Inflammatory Bowel Disease
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0659: Exploring Ferric Maltol: A Promising Alternative to IV Iron for Managing Chronic Iron Deficiency Anaemia in Inflammatory Bowel Disease Patients
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P065: Altered B cell expansion and maturation in Crohn's disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P065: Conservation of breast milk cytokine profiles in consecutive pregnancies of women with inflammatory bowel disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P065: Determination of the cytokine pattern of human colon organoids derived from Inflammatory Bowel Disease patients
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P065: Effects of gut bacteria on the intestinal immune cell composition and barrier function
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P065: Molecular landscape of early Crohn’s disease using an integrated approach of mRNA/miRNA profiling and genomics
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P065: Olfactory receptor, OR51E2 is a marker for innate immune cells in ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P065: REDD1/autophagy-driven NETosis promotes IL-1β-mediated inflammation in active ulcerative colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P066 Azathioprine linked with impaired intestinal epithelial regeneration in Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM